Clinical Trials
19 trialsNCT05546476 2026-06-03
PROACC-1
Pfizer
Phase 2 Completed
NCT03743051 2024-06-26
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
Phase 3 Completed
NCT03743064 2024-06-26
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
Phase 3 Completed
NCT04803305 2024-01-12
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Phase 1 Completed
NCT04299048 2023-12-14
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Phase 1 Completed
NCT04131426 2023-08-15
Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia
University of Rochester
Phase 1 Completed
NCT03960034 2022-04-15
LUCAX01
Instituto do Cancer do Estado de São Paulo
Completed
NCT00031785 2021-09-09
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT04879316 2021-05-12
ELY
Hôpital Cochin
Completed
NCT00866970 2020-07-09
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
CSL Behring
Phase 2 Completed
NCT02968979 2019-09-24
CacheMire
Chugai Pharma France
Completed
NCT00477919 2019-05-15
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
Completed
NCT01387269 2017-10-27
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT01387282 2017-10-27
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT01395914 2017-09-14
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT00040885 2016-12-07
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01433263 2016-03-02
Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas
Novartis
Phase 2 Completed
NCT00467844 2014-07-11
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
GTx
Phase 2 Completed
NCT00513357 2012-12-11
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed